Enhabit, Inc. (NYSE:EHAB) Receives $8.75 Average PT from Brokerages

Enhabit, Inc. (NYSE:EHAB) has earned a consensus recommendation of “Hold” from the six research firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $8.75.

A number of analysts recently commented on EHAB shares. Leerink Partners reaffirmed a “market perform” rating and issued a $8.00 target price (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and raised their price objective for the company from $8.25 to $9.50 in a research note on Monday, December 9th.

Insider Transactions at Enhabit

In related news, Director Jeffrey Bolton purchased 4,000 shares of the business’s stock in a transaction on Thursday, December 12th. The stock was acquired at an average price of $8.69 per share, for a total transaction of $34,760.00. Following the purchase, the director now owns 98,144 shares of the company’s stock, valued at approximately $852,871.36. This trade represents a 4.25 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Stuart M. Mcguigan acquired 15,000 shares of the stock in a transaction dated Tuesday, December 10th. The stock was bought at an average cost of $8.81 per share, with a total value of $132,150.00. Following the completion of the purchase, the director now owns 46,810 shares of the company’s stock, valued at approximately $412,396.10. The trade was a 47.15 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Enhabit

Several large investors have recently bought and sold shares of the stock. Jane Street Group LLC grew its stake in shares of Enhabit by 514.3% in the 3rd quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock worth $7,119,000 after acquiring an additional 754,395 shares in the last quarter. Marshall Wace LLP purchased a new position in Enhabit during the second quarter worth about $1,941,000. Systematic Financial Management LP grew its position in Enhabit by 12.2% in the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock worth $14,522,000 after purchasing an additional 199,235 shares in the last quarter. DekaBank Deutsche Girozentrale increased its stake in Enhabit by 52.3% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock valued at $4,306,000 after buying an additional 178,000 shares during the last quarter. Finally, Bardin Hill Management Partners LP lifted its position in shares of Enhabit by 927.4% during the 3rd quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company’s stock worth $1,377,000 after buying an additional 157,338 shares in the last quarter.

Enhabit Stock Performance

Shares of EHAB stock opened at $7.65 on Friday. The firm has a 50 day moving average of $7.64 and a 200-day moving average of $8.27. The company has a market cap of $384.67 million, a price-to-earnings ratio of -3.30 and a beta of 1.89. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit has a 52 week low of $6.85 and a 52 week high of $11.74.

Enhabit (NYSE:EHAB) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The company had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. During the same quarter in the previous year, the business posted $0.03 earnings per share. On average, equities analysts forecast that Enhabit will post 0.22 earnings per share for the current year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.